by MH Team | Feb 27, 2024 | White Blood Cells
TL;DR Myeloproliferative neoplasms (MPNs) are a group of chronic myeloid blood cancers characterized by overproduction of one or more types of blood cells in the bone marrow. Classifications ▾: Essential Thrombocythemia (ET): Increased platelet count Polycythemia Vera...
by MH Team | Feb 24, 2024 | White Blood Cells
TL;DR Leukemia is a cancer of the blood and bone marrow. It affects the cells responsible for fighting infection and carrying oxygen throughout the body. How does it occur? ▾ Normally, blood cells develop from stem cells in the bone marrow. In leukemia, the...
by MH Team | Feb 21, 2024 | White Blood Cells
TL;DR Lymphoma is a group of cancers affecting the lymphatic system, vital for immunity. It encompasses both malignant (cancerous) and benign (non-cancerous) forms. Key differences ▾ Malignant lymphoma: Uncontrolled cell growth in lymphocytes, potentially spreading...
by MH Team | Feb 17, 2024 | Lab Protocols, Transfusion Medicine
Procedure At A Glance The purpose serologic cross-matching (blood compatibility test) is to detect ABO incompatibility and clinically significant antibodies in recipient serum/plasma against donor red blood cells. Immediate Spin (IS) Phase Add 2 drops of Recipient...
by MH Team | Feb 11, 2024 | Commentaries, general
What is hemato-oncology (blood cancer)? Hemato-oncology specifically combines areas of hematology and oncology to diagnose and manage cancers that develop in the blood cells, bone marrow, lymph nodes, and other blood-related organs. Hemato-oncology is a fascinating...
Recent Comments